Scholarlink

<p>Internalizing problems are the most common mental health problems encountered in youths. This study investigated the efficacy of a transdiagnostic Internet-delivered intervention (REBTonAd), delivered over 6 weeks. Our study included Romanian youths (aged 11–17) with a primary diagnosis of an anxiety and/or depressive disorder. Eligible participants (<i>N</i> = 106; <i>M</i><sub>age</sub> = 12.83, SD = 1.63) were randomly assigned to the REBTonAd group (<i>n</i> = 53) or the waitlist condition (WL) (n = 53), with outcomes assessed at baseline, post-test, and 6-month follow-up. At the post-test, the remission rate and clinical reliable change indices were higher in the REBTonAd group. Internalizing problems were reduced more in the REBTonAd group, with a moderate effect size (standardized mean difference = −0.60, 95% CI −0.96 to −0.25). Future research needs to test the effectiveness of this intervention compared to disorder-specific treatments and investigate its cost-effectiveness. This trial was prospectively registered at ClinicalTrials.gov (NCT04179526).</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Transdiagnostic Internet-delivered intervention for children and adolescents with anxiety and depressive disorders: a randomized controlled trial

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月16日

查看全文
  • Anca Dobrean,
  • Costina-Ruxandra Poetar,
  • Ionuț-Stelian Florean,
  • Raluca Balan,
  • Gerhard Andersson

摘要

Internalizing problems are the most common mental health problems encountered in youths. This study investigated the efficacy of a transdiagnostic Internet-delivered intervention (REBTonAd), delivered over 6 weeks. Our study included Romanian youths (aged 11–17) with a primary diagnosis of an anxiety and/or depressive disorder. Eligible participants (N = 106; Mage = 12.83, SD = 1.63) were randomly assigned to the REBTonAd group (n = 53) or the waitlist condition (WL) (n = 53), with outcomes assessed at baseline, post-test, and 6-month follow-up. At the post-test, the remission rate and clinical reliable change indices were higher in the REBTonAd group. Internalizing problems were reduced more in the REBTonAd group, with a moderate effect size (standardized mean difference = −0.60, 95% CI −0.96 to −0.25). Future research needs to test the effectiveness of this intervention compared to disorder-specific treatments and investigate its cost-effectiveness. This trial was prospectively registered at ClinicalTrials.gov (NCT04179526).